Susan L. McGovern, Ph.D. - Publications

Affiliations: 
2003 Northwestern University, Evanston, IL 
Area:
GPCR, computational chemistry

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Grossberg A, Zhao Z, Walker G, Tsai J, Wang X, Lang F, Phan J, Ghia A, McGovern S, Mahajan A, Brown P, McAleer MF, Li J. Dose painting with Gamma Knife: Two techniques for delivering different doses to areas of recurrent or residual tumor after resection of brain metastases. Practical Radiation Oncology. PMID 26412338 DOI: 10.1016/j.prro.2015.08.001  0.84
2014 McGovern SL, Grosshans D, Mahajan A. Embryonal brain tumors. Cancer Journal (Sudbury, Mass.). 20: 397-402. PMID 25415685 DOI: 10.1097/PPO.0000000000000081  0.84
2014 McGovern SL, Okcu MF, Munsell MF, Kumbalasseriyil N, Grosshans DR, McAleer MF, Chintagumpala M, Khatua S, Mahajan A. Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. International Journal of Radiation Oncology, Biology, Physics. 90: 1143-52. PMID 25311260 DOI: 10.1016/j.ijrobp.2014.08.354  0.84
2014 Grosshans DR, Zhu XR, Melancon A, Allen PK, Poenisch F, Palmer M, McAleer MF, McGovern SL, Gillin M, DeMonte F, Chang EL, Brown PD, Mahajan A. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. International Journal of Radiation Oncology, Biology, Physics. 90: 540-6. PMID 25304948 DOI: 10.1016/j.ijrobp.2014.07.005  0.84
2014 Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, Chintagumpala M, Kahalley LS, McAleer MF, McGovern SL, Whitehead WE, Grosshans DR. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. International Journal of Radiation Oncology, Biology, Physics. 90: 354-61. PMID 25052561 DOI: 10.1016/j.ijrobp.2014.05.051  0.84
2014 Mcgovern SL. Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer: Yomo S, Hayashi M, Cho N (San-ai Hosp, Sakura-ku, Saitama, Japan) J Neurooncol 112:199-207, 2013 Breast Diseases. 25: 157-158. DOI: 10.1016/j.breastdis.2014.04.030  0.84
2013 Welsh JW, McGovern SL, Wefel JS, Komaki R, Brown PD, Soh HE. Reply to v.R. Bhatt et Al and m.C. Chamberlain. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3165-6. PMID 23943829 DOI: 10.1200/JCO.2013.50.7160  0.84
2013 Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, et al. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 895-902. PMID 23341526 DOI: 10.1200/JCO.2011.40.1174  0.84
2012 McGovern SL, Qi Y, Pusztai L, Symmans WF, Buchholz TA. Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer. Breast Cancer Research : Bcr. 14: R72. PMID 22559056 DOI: 10.1186/bcr3181  0.84
2012 McGovern SL, Mahajan A. Progress in radiotherapy for pediatric sarcomas. Current Oncology Reports. 14: 320-6. PMID 22532264 DOI: 10.1007/s11912-012-0235-y  0.84
2012 McGovern SL. Factors influencing survival in patients with breast cancer and single or solitary brain metastasis Breast Diseases. 23: 48-50. DOI: 10.1016/j.breastdis.2012.01.034  0.84
2010 McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. Journal of Neurosurgery. 112: 925-33. PMID 19799498 DOI: 10.3171/2009.9.JNS09617  0.84
2010 McGovern SL, Williams MD, Weber RS, Sabichi A, Chambers MS, Martin JW, Chao KS. Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head & Neck. 32: 1118-24. PMID 19572386 DOI: 10.1002/hed.21171  0.84
2010 McGovern SL, Ballo MT. Radiation oncology in skin cancer treatment Skin Cancer Management: a Practical Approach. 259-271. DOI: 10.1007/978-0-387-88495-0_19  0.84
2009 McGovern SL, Liao Z, Bucci MK, McAleer MF, Jeter MD, Chang JY, O'Reilly MS, Cox JD, Allen PK, Komaki R. Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? Cancer. 115: 3233-42. PMID 19472405 DOI: 10.1002/cncr.24361  0.84
2008 Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, Aldape K, Cha S, Kuo MD. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proceedings of the National Academy of Sciences of the United States of America. 105: 5213-8. PMID 18362333 DOI: 10.1073/pnas.0801279105  0.84
2006 McGovern SL. Promiscuous ligands Comprehensive Medicinal Chemistry Ii. 2: 737-752.  0.84
2003 Seidler J, McGovern SL, Doman TN, Shoichet BK. Identification and prediction of promiscuous aggregating inhibitors among known drugs. Journal of Medicinal Chemistry. 46: 4477-86. PMID 14521410 DOI: 10.1021/jm030191r  0.84
2003 McGovern SL, Helfand BT, Feng B, Shoichet BK. A specific mechanism of nonspecific inhibition. Journal of Medicinal Chemistry. 46: 4265-72. PMID 13678405 DOI: 10.1021/jm030266r  0.84
2003 McGovern SL, Shoichet BK. Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes. Journal of Medicinal Chemistry. 46: 2895-907. PMID 12825931 DOI: 10.1021/jm0300330  0.84
2003 McGovern SL, Shoichet BK. Kinase inhibitors: not just for kinases anymore. Journal of Medicinal Chemistry. 46: 1478-83. PMID 12672248 DOI: 10.1021/jm020427b  0.84
2002 Shoichet BK, McGovern SL, Wei B, Irwin JJ. Lead discovery using molecular docking. Current Opinion in Chemical Biology. 6: 439-46. PMID 12133718 DOI: 10.1016/S1367-5931(02)00339-3  0.84
2002 Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Kurumbail R, Stallings WC, Connolly DT, Shoichet BK. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. Journal of Medicinal Chemistry. 45: 2213-21. PMID 12014959 DOI: 10.1021/jm010548w  0.84
2002 McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. Journal of Medicinal Chemistry. 45: 1712-22. PMID 11931626 DOI: 10.1021/jm010533y  0.84
2002 Irwin JJ, Lorber DM, McGovern SL, Wei B, Shoichet BK. Molecular docking and drug design 2002 International Conference On Computational Nanoscience and Nanotechnology - Iccn 2002. 50-51.  0.84
1999 Beadle BM, McGovern SL, Patera A, Shoichet BK. Functional analyses of AmpC beta-lactamase through differential stability. Protein Science : a Publication of the Protein Society. 8: 1816-24. PMID 10493583 DOI: 10.1110/ps.8.9.1816  0.84
Show low-probability matches.